ANALYSIS: Top Glove bets on pandemic boom to propel ambitious US$1.9bil HK listing

KUALA LUMPUR (Reuters) - Top Glove Corp Bhd is betting that pandemic-induced sales can provide enough fuel for its US$1.9 billion Hong Kong listing to break through the headwind of U.S. sanctions and the prospect of slower growth as vaccinations become widespread.

Analysts said the unknown pace of vaccination programmes mean the world's largest medical gloves maker could command a higher price for its stock by listing sooner rather than later, while the firm when announcing its plan on Friday talked up post-pandemic sales likely exceeding pre-pandemic levels.